Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Grail Inc GRAL

Healthcare Biotechnology
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can... see more

Recent & Breaking News (NDAQ:GRAL)

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire May 30, 2025

GRAIL to Present at Jefferies Global Healthcare Conference 2025

PR Newswire May 21, 2025

GRAIL Reports First Quarter 2025 Financial Results

PR Newswire May 13, 2025

GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test

PR Newswire May 12, 2025

GRAIL to Announce First Quarter 2025 Financial Results

PR Newswire April 29, 2025

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

PR Newswire April 22, 2025

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire February 26, 2025

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

PR Newswire February 25, 2025

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

PR Newswire February 21, 2025

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire February 20, 2025

GRAIL to Announce Fourth Quarter 2024 Financial Results

PR Newswire February 12, 2025

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

PR Newswire February 12, 2025

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

PR Newswire January 13, 2025

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire December 18, 2024

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire December 3, 2024

GRAIL to Participate in Upcoming Investor Conferences

PR Newswire November 19, 2024

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

PR Newswire November 18, 2024

GRAIL Reports Third Quarter 2024 Financial Results

PR Newswire November 12, 2024

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PR Newswire November 4, 2024

GRAIL to Announce Third Quarter 2024 Financial Results

PR Newswire October 29, 2024